The impact of initial symptoms on survival time in advanced non-small cell lung cancer

被引：0

|

作者：

Miyawaki, T. ^{[1
]}

Yagishita, S. ^{[2
]}

Ko, R. ^{[3
]}

Suzuki, Y. ^{[1
]}

Matsumoto, N. ^{[1
]}

Hara, M. ^{[1
]}

Iwakami, N. ^{[1
]}

Fujii, M. ^{[1
]}

Iwakami, S-I. ^{[1
]}

Takahashi, K. ^{[3
]}

机构：

[1] Juntendo Univ, Shizuoka Hosp, Dept Resp Med, Shizuoka, Japan

[2] Juntendo Univ, Urayasu Hosp, Dept Resp Med, Urayasu, Japan

[3] Juntendo Univ Hosp, Dept Resp Med, Tokyo, Japan

来源：

ANNALS OF ONCOLOGY | 2016年 / 27卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

479P

引用

收藏

页数：1

相关论文

共 50 条

[31] Chemotherapy for advanced non-small cell lung cancer
Herbst, RS
Dang, NH
Skarin, AT
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1997, 11 (03) : 473 - &
[32] Chemotherapy in advanced non-small cell lung cancer
Evans, T
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 26 (03) : 304 - 313
[33] Chemotherapy for advanced non-small cell lung cancer
Einhorn, L.
LUNG CANCER, 2006, 52 : S1 - S2
[34] Chemotherapy for advanced non-small cell lung cancer
Manegold, C
SEMINARS IN ONCOLOGY, 2001, 28 (02) : 1 - 6
[35] Locally advanced non-small cell lung cancer
Pulla, MP
Sánchez, FV
REVISTA CLINICA ESPANOLA, 2005, 205 (08): : 392 - 394
[36] Atezolizumab in advanced non-small cell lung cancer
Ilie, Marius
Hofman, Paul
JOURNAL OF THORACIC DISEASE, 2017, 9 (10) : 3603 - 3606
[37] Cetuximab in advanced non-small cell lung cancer
Rossi, Antonio
Maione, Paolo
Gridelli, Cesare
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 59 (02) : 139 - 149
[38] Chemotherapy of advanced non-small cell lung cancer
Jassem, J
ANNALS OF ONCOLOGY, 1999, 10 : 77 - 82
[39] Advanced non-small cell lung cancer.
Edelman M.J.
Khanwani S.L.
Current Treatment Options in Oncology, 2001, 2 (1) : 51 - 62
[40] Gefitinib for advanced non-small cell lung cancer
Sim, Esther H. A.
Yang, Ian A.
Wood-Baker, Richard
Bowman, Rayleen V.
Fong, Kwun M.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):

← 1 2 3 4 5 →